04:33 AM EDT, 09/11/2024 (MT Newswires) -- Relay Therapeutics ( RLAY ) said late Tuesday it priced an underwritten public offering of about 28.6 million common shares at $7 per share for gross proceeds of about $200 million.

Underwriters have been granted a 30-day option to buy up to about 4.3 million additional shares.

The offering is set to close Thursday.

Shares of Relay Therapeutics ( RLAY ) fell more than 12% in pre-bell activity Wednesday.

Price: 7.84, Change: -1.16, Percent Change: -12.89